128 related articles for article (PubMed ID: 31076010)
1. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds.
Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H
SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010
[TBL] [Abstract][Full Text] [Related]
2. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
3. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
4. Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry.
Cai X; Walker A; Cheng C; Paiva A; Li Y; Kolb J; Herbst J; Shou W; Weller H
J Pharm Sci; 2012 Aug; 101(8):2755-62. PubMed ID: 22611052
[TBL] [Abstract][Full Text] [Related]
5. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
[TBL] [Abstract][Full Text] [Related]
6. Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2002 Nov; 54(3):319-24. PubMed ID: 12445562
[TBL] [Abstract][Full Text] [Related]
7. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.
Krishna G; Chen K; Lin C; Nomeir AA
Int J Pharm; 2001 Jul; 222(1):77-89. PubMed ID: 11404034
[TBL] [Abstract][Full Text] [Related]
8. Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism.
Li Y; Shin YG; Yu C; Kosmeder JW; Hirschelman WH; Pezzuto JM; van Breemen RB
Comb Chem High Throughput Screen; 2003 Dec; 6(8):757-67. PubMed ID: 14683481
[TBL] [Abstract][Full Text] [Related]
9. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.
Wang Z; Hop CE; Leung KH; Pang J
J Mass Spectrom; 2000 Jan; 35(1):71-6. PubMed ID: 10633236
[TBL] [Abstract][Full Text] [Related]
10. Caco-2 cell permeability assays to measure drug absorption.
van Breemen RB; Li Y
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):175-85. PubMed ID: 16922635
[TBL] [Abstract][Full Text] [Related]
11. Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers.
Kokate A; Li X; Jasti B
Invest New Drugs; 2007 Jun; 25(3):197-203. PubMed ID: 17146731
[TBL] [Abstract][Full Text] [Related]
12. An in vitro toolbox to accelerate anti-malarial drug discovery and development.
Charman SA; Andreu A; Barker H; Blundell S; Campbell A; Campbell M; Chen G; Chiu FCK; Crighton E; Katneni K; Morizzi J; Patil R; Pham T; Ryan E; Saunders J; Shackleford DM; White KL; Almond L; Dickins M; Smith DA; Moehrle JJ; Burrows JN; Abla N
Malar J; 2020 Jan; 19(1):1. PubMed ID: 31898492
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the Caco-2 permeability assay to screen drug compounds for intestinal absorption and efflux.
Press B
Methods Mol Biol; 2011; 763():139-54. PubMed ID: 21874449
[TBL] [Abstract][Full Text] [Related]
14. A strategy to reduce biliary clearance in early drug discovery.
Rioux N; Bellavance E; Poirier H; Dupuis M; Garneau M; Ribadeneira MD; Duan J
J Pharmacol Toxicol Methods; 2013; 68(3):346-8. PubMed ID: 23518065
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of the caco-2 permeability assay using experimental design methodology.
Lakeram M; Lockley DJ; Pendlington R; Forbes B
Pharm Res; 2008 Jul; 25(7):1544-51. PubMed ID: 18293061
[TBL] [Abstract][Full Text] [Related]
16. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283
[TBL] [Abstract][Full Text] [Related]
17. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.
Skolnik S; Lin X; Wang J; Chen XH; He T; Zhang B
J Pharm Sci; 2010 Jul; 99(7):3246-65. PubMed ID: 20166204
[TBL] [Abstract][Full Text] [Related]
18. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.
Liu H; Sabus C; Carter GT; Du C; Avdeef A; Tischler M
Pharm Res; 2003 Nov; 20(11):1820-6. PubMed ID: 14661927
[TBL] [Abstract][Full Text] [Related]
19. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay.
Cai X; Patel S; Huang C; Paiva A; Sun Y; Barker G; Weller H; Shou W
Xenobiotica; 2022 Jul; 52(7):742-750. PubMed ID: 36217915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
